Skip to main content
. 2003 Feb;77(3):1727–1737. doi: 10.1128/JVI.77.3.1727-1737.2003

TABLE 1.

Outcome of LCMV/WE infection of rhesus macaques

Monkey Inoculation route and dose (PFU) Outcome Viremiaa Virus in liverb Antibody responsec
Rh-iv3 i.v., 103 Died 1.0 × 106 5.5 × 105 <2 (E), negative (N)
Rh-iv6 i.v., 106 Died 1.2 × 107 1.0 × 108 <2 (E), negative (N)
Rh-ig6a i.g., 106 Survived PCR negative PCR negative <2 (E), negative (N)
Rh-ig6b i.g., 106 Survived PCR negative PCR negative <2 (E), negative (N)
Rh-ig7a i.g., 107 Survived PCR negative PCR negative <2 (E), negative (N)
Rh-ig7b i.g., 107 Illness and full recovery 8.8 × 104 PCR positive and negatived 7.2 (E), 3.1 (N)
a

For Rh-iv3 and Rh-iv6, viremia on day of death is shown (in PFU per milliliter). For Rh-ig7b, viremia was detected on day 28 p.i. and was not detectable by plaque assay and RT-PCR on day 42 and later.

b

RT-PCR was performed with RNA samples extracted from livers of Rh-iv3 and Rh-iv6 on the day of death and from Rh-ig6a and Rh-ig6b on day 28, when the animals were sacrificed. For Rh-ig7a and Rh-ig7b, biopsies were performed before the infection and at weeks 4 and 11 p.i. Titers are in PFU per gram of tissue.

c

Antibody response was evaluated in ELISA (E) and in plaque reduction neutralization assay (N) and expressed as 1/log10 of the final serum dilution (see Materials and Methods for details).

d

Rh-ig7b was RT-PCR negative for virus before infection and at weeks 2 and 6 after infection and was RT-PCR positive at week 4 after infection.